2CBecca
In-game article clicks load inline without leaving the challenge.
2CBecca, also known as 4-(4-bromo-2,5-dimethoxyphenyl)-1,2,3,4-tetrahydroisoquinoline, is a serotonin receptor modulator of the phenethylamine, 2C, and N-benzylphenethylamine families. It is a cyclized phenethylamine analogue of the serotonergic psychedelic 25B-NBOMe in which the N-benzylethylamine side chain has been cyclized to form a tetrahydroisoquinoline ring. The drug shows affinity for the serotonin 5-HT2A and 5-HT2C receptors (Ki = 39–71nM and 267–850nM, respectively). 2CBecca was first described in the scientific literature by Michael Robert Braden of the lab of David E. Nichols at Purdue University in 2007.
See also
- Substituted methoxyphenethylamine
- Cyclized phenethylamine
- 2C-B-3PIP
- LPH-5
- DEMPDHPCA-2C-D
- Z3517967757
- 2CJP
- 2CLisaB
- 2C-B-3PIP-NBOMe
- 2C-B-3PIP-POMe